Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Association between MDR1 C3435T polymorphism and risk of breast cancer.

Wang Z, Wang T, Bian J.

Gene. 2013 Dec 10;532(1):94-9. doi: 10.1016/j.gene.2013.09.050. Epub 2013 Sep 23.

PMID:
24070710
2.

MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies.

Sheng X, Zhang L, Tong N, Luo D, Wang M, Xu M, Zhang Z.

Mol Biol Rep. 2012 Jul;39(7):7237-49. doi: 10.1007/s11033-012-1554-7. Epub 2012 Feb 4.

PMID:
22311042
3.

MDR1 C3435T polymorphism in patients with breast cancer.

Turgut S, Yaren A, Kursunluoglu R, Turgut G.

Arch Med Res. 2007 Jul;38(5):539-44. Epub 2007 Apr 26.

PMID:
17560460
4.

MDR1 gene C3435T polymorphism and cancer risk: a meta-analysis of 34 case-control studies.

Wang J, Wang B, Bi J, Li K, Di J.

J Cancer Res Clin Oncol. 2012 Jun;138(6):979-89. doi: 10.1007/s00432-012-1171-9. Epub 2012 Feb 23.

PMID:
22358302
5.

Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis.

Lu PH, Wei MX, Yang J, Liu X, Tao GQ, Shen W, Chen MB.

Breast Cancer Res Treat. 2011 Jan;125(2):537-43. doi: 10.1007/s10549-010-1033-6. Epub 2010 Jul 13.

PMID:
20625815
6.

Lack of association between MDR1 C3435T polymorphism and chemotherapy response in advanced breast cancer patients: evidence from current studies.

Chen G, Quan S, Hu Q, Wang L, Xia X, Wu J.

Mol Biol Rep. 2012 May;39(5):5161-8. doi: 10.1007/s11033-011-1312-2. Epub 2011 Dec 9.

PMID:
22160574
7.

MDR1 C3435T polymorphism and inflammatory bowel disease risk: a meta-analysis.

Wang J, Guo X, Yu S, Zhang J, Song J, Ji M, Cao Z, Wang J, Liu Y, Dong W.

Mol Biol Rep. 2014;41(4):2679-85. doi: 10.1007/s11033-014-3127-4. Epub 2014 Jan 22.

PMID:
24449364
8.

Methionine synthase A2756G polymorphism and breast cancer risk: an up-to-date meta-analysis.

Zhong S, Xu J, Li W, Chen Z, Ma T, Zhao J.

Gene. 2013 Sep 25;527(2):510-5. doi: 10.1016/j.gene.2013.06.054. Epub 2013 Jul 9.

PMID:
23845785
9.

Variant genotypes of MDR1 C3435T increase the risk of leukemia: evidence from 10 case-control studies.

Qian X, Cao S, Yang G, Dong J, Jin G, Shen Y, Hu Z.

Leuk Lymphoma. 2012 Jun;53(6):1183-7. doi: 10.3109/10428194.2011.641179. Epub 2012 Jan 3.

PMID:
22088099
10.

Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.

Chen MB, Li C, Shen WX, Guo YJ, Shen W, Lu PH.

Mol Biol Rep. 2011 Oct;38(7):4687-95. doi: 10.1007/s11033-010-0603-3. Epub 2010 Dec 2.

PMID:
21127985
11.

Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes.

Wu H, Kang H, Liu Y, Tong W, Liu D, Yang X, Lian M, Yao W, Zhao H, Huang D, Sha X, Wang E, Wei M.

J Cancer Res Clin Oncol. 2012 Sep;138(9):1449-62. doi: 10.1007/s00432-012-1209-z. Epub 2012 Apr 19.

PMID:
22526155
12.

Association of C3435T single-nucleotide polymorphism of MDR1 gene with breast cancer in an Iranian population.

Tatari F, Salek R, Mosaffa F, Khedri A, Behravan J.

DNA Cell Biol. 2009 May;28(5):259-63. doi: 10.1089/dna.2008.0826.

PMID:
19388849
13.

Association between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibility : a meta-analysis based on 11,339 subjects.

Zhao L, Li K, Li W, Yang Z.

Tumour Biol. 2013 Jun;34(3):1949-57. doi: 10.1007/s13277-013-0740-0. Epub 2013 Mar 16.

PMID:
23504525
14.

Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients.

Taheri M, Mahjoubi F, Omranipour R.

Genet Mol Res. 2010 Jan 12;9(1):34-40. doi: 10.4238/vol9-1gmr669.

15.

Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids.

Youssef DM, Attia TA, El-Shal AS, Abduelometty FA.

Gene. 2013 Nov 10;530(2):201-7. doi: 10.1016/j.gene.2013.08.045. Epub 2013 Aug 27.

PMID:
23994685
16.

MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia.

Jamroziak K, Balcerczak E, Smolewski P, Robey RW, Cebula B, Panczyk M, Kowalczyk M, Szmigielska-Kapłon A, Mirowski M, Bates SE, Robak T.

Pharmacol Rep. 2006 Sep-Oct;58(5):720-8.

17.

The association of MDR1 C3435T and G2677T/A polymorphisms with plasma platelet-activating factor levels and coronary artery disease risk in Turkish population.

Ayaz G, Batar B, Kanigur G, Guven M, Onaran I, Karadag B, Ilerigelen B, Dirican A, Ulutin T.

Gene. 2013 Sep 15;527(1):301-5. doi: 10.1016/j.gene.2013.06.046. Epub 2013 Jun 29.

PMID:
23816407
18.

Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia.

Jamroziak K, Młynarski W, Balcerczak E, Mistygacz M, Trelinska J, Mirowski M, Bodalski J, Robak T.

Eur J Haematol. 2004 May;72(5):314-21.

PMID:
15059065
19.

Association of CDKN1B gene polymorphisms with susceptibility to breast cancer: a meta-analysis.

Xiang H, Li H, Ge W, Wu W, Gao M, Wang W, Hong L, Jiang D, Zhang C.

Mol Biol Rep. 2013 Nov;40(11):6371-7.

PMID:
24078094
20.

MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese.

Sugimoto M, Furuta T, Shirai N, Kodaira C, Nishino M, Yamade M, Ikuma M, Sugimura H, Ishizaki T, Hishida A.

Life Sci. 2008 Aug 15;83(7-8):301-4. doi: 10.1016/j.lfs.2008.06.022. Epub 2008 Jul 3.

PMID:
18644389

Supplemental Content

Support Center